The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

SMALL-CAP WINNERS & LOSERS: Dr Martens Puts Best Foot Forward

Wed, 03rd Feb 2021 10:50

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Wednesday.

----------

SMALL-CAP - WINNERS

----------

Dr Martens, 452.16p, up 22% from initial public offering price of 370p. The iconic boot maker said its entire share capital has begun trading on London's Main Market on Wednesday, with a market value of around GBP4.5 billion putting Dr Martens easily in contention for a spot in the FTSE 250 index of mid-caps.

----------

Volution Group, up 5.5% at 308.57 pence, 12-month range 122.46p-313p. The ventilation products supplier said it is "pleased" with its strong trading performance and also has agreed to buy Swedish ventilation equipment maker Nordiska Klimatfabriken.

----------

STV Group up 5.0% at 347.56p, 12-month range, 210p-452.83p. The Glasgow-based television broadcaster said it saw a record-breaking performance in January for its free streaming service STV Player, with the release of exclusive drama box sets driving viewer growth. STV said total steams for STV Player are up over 100% to 12.5 million streams when compared to a year prior. The number of monthly active users on the service grew by 20% in January.

----------

Standard Life Investments Property, up 4.9% at 60.80p, 12-month range 43.51p-993p. The property investor said net asset value per share as at December 31 was up 4.1% to 82.0p from 78.8p.

----------

4D Pharma, up 4.6% at 120.83p, 12-month range 23.5p-183p. The pharmaceutical company said enrolment is progressing well both for part B of the MRx0518 and Keytruda combination study and for its pancreatic cancer study. 4D said 24 additional patients across five active US sites have been treated in part B of the study, consisting of 12 patients with renal cell carcinoma, 9 patients with non-small cell lung cancer, and 3 bladder cancer patients.

----------

SMALL-CAP - LOSERS

----------

Bacanora Lithium, down 15% at 47.40p, 12-month range 14.5p-69p. The lithium explorer said it successfully raised approximately USD65 million through the placing of shares as well as a retail offer. A total of 101.4 million shares were placed at 45 pence each, raising proceeds of about USD62 million, while an extra USD3 million was raised after retail and other investors subscribed for 5.6 million shares.

----------

Porvair, down 2.5% at 525.75p, 12-month range 370p-796.47p. The filtration, laboratory and environmental technology firm's shares were continuing to fall after it said earlier this week that near-term trading remains unpredictable and continued to withhold earnings guidance. The stock is down 8.4% since last Thursday.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
8 Jun 2022 16:02

UK shareholder meetings calendar - next 7 days

20 May 2022 16:00

UK dividends calendar - next 7 days

5 May 2022 16:06

UK dividends calendar - next 7 days

3 May 2022 21:55

TRADING UPDATES: Vela, Standard Life Investments up portfolio value

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

18 Feb 2022 16:16

UK dividends calendar - next 7 days

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.